Amundi Asset Management US’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Amundi Asset Management US's EXAS Position: Q1 2021 in Review
Amundi Asset Management US increased its Exact Sciences (EXAS) stake by 19% in Q1 2021, buying an estimated $33.5M and bringing the position to 1,507,798 shares worth $199M. The position accounts for 0.15% of the portfolio, ranked #156.
Amundi Asset Management US first reported a position in EXAS in Q1 2017 and has held it in 17 quarters since. 646 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.
- Amundi Asset Management US held 1,507,798 shares of Exact Sciences worth $199M as of Q1 2021.
- Amundi Asset Management US bought 244,770 Exact Sciences shares in Q1 2021, an estimated $33.5M.
- Exact Sciences made up 0.15% of Amundi Asset Management US's portfolio in Q1 2021, its #156 holding.
- Amundi Asset Management US first reported a position in Exact Sciences in Q1 2017 and has held it in 17 quarters since.
- 646 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.
Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.